Correlation Between BB Biotech and Allianz SE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BB Biotech and Allianz SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and Allianz SE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and Allianz SE, you can compare the effects of market volatilities on BB Biotech and Allianz SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of Allianz SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and Allianz SE.

Diversification Opportunities for BB Biotech and Allianz SE

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BBZA and Allianz is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and Allianz SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allianz SE and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with Allianz SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allianz SE has no effect on the direction of BB Biotech i.e., BB Biotech and Allianz SE go up and down completely randomly.

Pair Corralation between BB Biotech and Allianz SE

Assuming the 90 days trading horizon BB Biotech AG is expected to generate 1.99 times more return on investment than Allianz SE. However, BB Biotech is 1.99 times more volatile than Allianz SE. It trades about 0.1 of its potential returns per unit of risk. Allianz SE is currently generating about -0.09 per unit of risk. If you would invest  3,880  in BB Biotech AG on August 29, 2024 and sell it today you would earn a total of  125.00  from holding BB Biotech AG or generate 3.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

BB Biotech AG  vs.  Allianz SE

 Performance 
       Timeline  
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BB Biotech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Allianz SE 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Allianz SE are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Allianz SE is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

BB Biotech and Allianz SE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BB Biotech and Allianz SE

The main advantage of trading using opposite BB Biotech and Allianz SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, Allianz SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allianz SE will offset losses from the drop in Allianz SE's long position.
The idea behind BB Biotech AG and Allianz SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Directory
Find actively traded commodities issued by global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years